Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
Eben L. Rosenthal(University of Alabama at Birmingham), Kurt R. Zinn(Michigan State University), Lisle M. Nabell(Memorial Sloan Kettering Cancer Center), Anthony B. Morlandt(University of Alabama at Birmingham), Theresa V. Strong(University of Alabama at Birmingham), Margie Brandwein-Gensler(University of Alabama at Birmingham), Cecelia E. Schmalbach(University of Alabama at Birmingham), Yolanda E. Hartman(University of Alabama at Birmingham), Melissa L. Korb(University of Alabama at Birmingham), William R. Carroll(University of Alabama at Birmingham), Esther de Boer(University Medical Center Groningen), Jason M. Warram(University of Alabama at Birmingham), Garima Agarwal(Indian Institute of Science Bangalore), Thomas K. Chung(University of Alabama at Birmingham), Lisa Clemons(University of Alabama at Birmingham), Joshua Richman(University of Alabama at Birmingham)
Cited by 477
Related Papers
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
|Blood|2007|328
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung
|Nature Biotechnology|2007|305
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers
|Clinical Cancer Research|2010|250
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles
|Journal of Immunological Methods|2001|214